Latest 10-K annual reports

NASDAQ
FGI Industries experienced a revenue increase of 12.4% in 2024, driven by growth in sanitaryware, shower systems, and custom kitchen cabinetry, but reported a net loss due to increased operating expenses and other factors.
NASDAQ
Sonim Technologies transitions from low-margin white label products, anticipates revenue growth in 2025 with new product launches, and focuses on expanding its rugged enterprise and public sector markets.
NASDAQ
Nutex Health's 2024 10-K filing highlights strategic growth, regulatory navigation, and financial performance amid evolving healthcare dynamics.
NASDAQ
ClearSign Technologies Corporation reports a revenue increase of 49.6% for fiscal year 2024, driven by increased process burner shipments and strategic market focus.
NASDAQ
Data Storage Corporation's 2024 annual report reveals a slight increase in revenue and net income, driven by growth in cloud infrastructure and disaster recovery services.
NASDAQ
Synergy CHC Corp.'s 2024 results reflect a decrease in revenue due to a FOCUSfactor rebranding, alongside strategic debt restructuring and ongoing efforts to expand into new markets.
Inspire Veterinary Partners' 2024 annual report reveals a $14.3 million net loss and raises concerns about the company's ability to continue as a going concern.
NASDAQ
ASP Isotopes Inc. reports a net loss for 2024 while advancing commercial production of enriched isotopes and pursuing HALEU production.
NASDAQ
Petco finalizes separation agreement with executive John Zavada, including a lump sum payment and accelerated vesting of stock units.
OID
Tradewinds Universal's 10-K filing reveals a year of revenue growth driven by protein bar sales, licensing rights, and affiliate marketing, alongside ongoing efforts to expand its product line and explore green business opportunities.
NASDAQ
Genprex, Inc. files its 10-K, reporting a net loss for 2024 and providing updates on its clinical development programs in oncology and diabetes.
OTC.Pink
ProPhase Labs reports a significant revenue decrease in 2024 due to reduced diagnostic services, while focusing on genomics and biopharmaceutical growth.
OTC.Pink
Titan Environmental Solutions' 10-K filing reveals a history of losses, details its capital structure, and outlines its strategy for growth in the environmental solutions sector.
NASDAQ
TuHURA Biosciences details its 2024 financial results and provides an update on its clinical programs, including the planned Phase 3 trial for IFx-2.0 and the proposed merger with Kineta, Inc.
OID
Innovative Payment Solutions' 2024 annual report reveals substantial net losses and raises concerns about the company's ability to continue as a going concern.
OID
New Peoples Bankshares, Inc. announces a $1.0 million increase in net income for 2024, driven by asset growth and strategic initiatives, while navigating non-recurring expenses and preparing for a core system conversion.
NASDAQ
CaliberCos Inc.'s 10-K filing reveals a year of mixed performance, with revenue declines offset by expense reductions, and ongoing efforts to address liquidity concerns and debt obligations.
NASDAQ
Binah Capital Group's 2024 results show stable revenue with a net loss, reflecting costs associated with becoming a public company.
NASDAQ
Red Cat Holdings files its transition report on Form 10-KT, detailing its business overview, key accomplishments, and financial performance for the eight-month period ended December 31, 2024.
NASDAQ
Phunware's 2024 10-K filing highlights continued losses, a strategic shift towards AI-driven solutions, and significant changes in executive leadership.
USA Rare Earth outlines its capital stock structure, including common stock, preferred stock, and warrants, in its annual report on Form 10-K.
NASDAQ
Odyssey Marine Exploration reports its 2024 financial results, highlighting a NAFTA arbitration award in its favor and a new joint venture for fertilizer production in Mexico.
NASDAQ
Sky Quarry Inc.'s 2024 10-K filing reveals a substantial net loss driven by decreased sales, refinery shutdowns, and increased operating expenses, despite ongoing efforts to retrofit facilities and expand into asphalt shingle recycling.
NASDAQ
T Stamp Inc.'s 2024 10-K filing reveals a widened net loss alongside strategic shifts towards AI integration and partnerships.
AMEX
Volato Group, Inc. reports a 30% increase in revenue for fiscal year 2024, driven by aircraft sales, while transitioning its business model towards software solutions and aircraft sales.
OTC.Pink
Reliability Inc. saw revenue growth in 2024, driven by its EOR segment, but still reported a net loss due to margin compression and legal expenses related to disputes with the Vivos Group.
NASDAQ
Israel Acquisitions Corp's 10-K filing details their financials, the Gadfin business combination agreement, and risks facing the company.
NASDAQ
Capstone Holding Corp. outlines its long-term growth strategy focused on building products distribution and manufacturing, leveraging market conditions and strategic acquisitions.
Datavault AI Inc.'s 2024 annual report details its strategic shift towards Web 3.0 data management and acoustic science innovations, marked by key acquisitions and financial activities.
Li-Cycle's 10-K filing reveals substantial doubt about its ability to continue as a going concern due to ongoing losses, a paused Rochester Hub project, and the need for additional financing.